Form CORRESP - Correspondence:
SEC Accession No. 0001104659-21-085723
Filing Date
2021-06-25
Accepted
2021-06-25 16:16:08
Documents
4

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 12612
2 GRAPHIC tm2120744d1_corresp-img001.jpg GRAPHIC 10949
3 GRAPHIC tm2120744d1_corresp-img002.jpg GRAPHIC 3305
4 GRAPHIC tm2120744d1_corresp-img003.jpg GRAPHIC 4600
  Complete submission text file 0001104659-21-085723.txt   40051
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

EIN.: 981130690 | State of Incorp.: L2
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations